
Nabriva Therapeutics plc NBRV
Quarterly report 2023-Q2
added 05-16-2026
Nabriva Therapeutics plc Total Inventories 2011-2026 | NBRV
Annual Total Inventories Nabriva Therapeutics plc
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 9.68 M | 14.5 M | 5.82 M | 682 K | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 14.5 M | 682 K | 7.67 M |
Quarterly Total Inventories Nabriva Therapeutics plc
| 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 9.68 M | 9.03 M | 9.68 M | 17.3 M | 15.5 M | 15.6 M | 14.5 M | 15.6 M | 10.1 M | 8.97 M | 5.82 M | 5.8 M | 5.2 M | 4.22 M | 682 K | 162 K | 682 K | 682 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 17.3 M | 162 K | 8.3 M |
Total Inventories of other stocks in the Biotechnology industry
| Issuer | Total Inventories | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Happiness Biotech Group Limited
HAPP
|
653 K | - | 1.35 % | $ 17.8 M | ||
|
Coherus BioSciences
CHRS
|
3.17 M | $ 1.59 | -3.64 % | $ 186 M | ||
|
Berkeley Lights
BLI
|
18.9 M | - | -7.31 % | $ 87 M | ||
|
Cyclacel Pharmaceuticals
CYCCP
|
1.38 M | - | -4.36 % | $ 27 M | ||
|
Anika Therapeutics
ANIK
|
18.8 M | $ 14.53 | -2.48 % | $ 208 M | ||
|
Albireo Pharma
ALBO
|
194 K | - | -0.23 % | $ 916 M | ||
|
Arcutis Biotherapeutics
ARQT
|
22.6 M | $ 21.46 | 0.09 % | $ 2.73 B |